Your session is about to expire
← Back to Search
Peer Support Intervention for COVID-19 Related Mental Health Issues (RIWP+ Trial)
N/A
Waitlist Available
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up all 7 timepoints over 36 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a peer support intervention to help Latinx and Black immigrants and refugees cope with mental health, financial, and stress-related problems caused by the COVID-19 pandemic.
Who is the study for?
This trial is for Latinx immigrants and African refugees aged 18 or older living in New Mexico. It's not open to those who've used certain community services within the last year or have severe mental illness that prevents group participation.
What is being tested?
The study tests a peer advocacy and social support program called Refugee and Immigrant Well-being Project, aiming to improve mental health, financial stability, and reduce stress among Latinx and Black communities affected by COVID-19.
What are the potential side effects?
Since this intervention involves social support rather than medication, there are no direct medical side effects. However, discussing sensitive topics may cause emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ all 7 timepoints over 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~all 7 timepoints over 36 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Daily Stressors
Economic Precarity
Physical Health
+1 moreSecondary study objectives
Access to Resources
Cultural Connectedness
Discrimination
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Refugee & Immigrant Well-being Project (RIWP) InterventionExperimental Treatment1 Intervention
6-month mental health intervention that pairs university students with newcomers to engage in mutual learning, resource mobilization, and social change efforts
Group II: Treatment-as-usual Waitlist Control GroupActive Control1 Intervention
participants recruited from community-based organizations receive usual services from community-based organizations and may participate in RIWP intervention in Year 3
Group III: Random Sample of Latinx ImmigrantsActive Control1 Intervention
random sample comparison group of Latinx immigrants who are NOT randomly assigned to a treatment condition
Find a Location
Who is running the clinical trial?
University of New MexicoLead Sponsor
384 Previous Clinical Trials
3,524,742 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,738,753 Total Patients Enrolled
11 Trials studying Mental Health Disorders
2,860 Patients Enrolled for Mental Health Disorders
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a Latinx immigrant or African refugee over 18 living in New Mexico.I do not have severe mental health issues that prevent me from joining group activities.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment-as-usual Waitlist Control Group
- Group 2: Refugee & Immigrant Well-being Project (RIWP) Intervention
- Group 3: Random Sample of Latinx Immigrants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger